SlideShare a Scribd company logo
PENCEGAHAN DAN PENGENDALIAN
PLEBITIS
Disampaikan
Pada Pelatihan Pemasangan Infuse
Pada tanggal 15 Februari 2020
POKOK BAHASAN
 Pendahuluan
 Pengertian
 Faktor –faktor yang mempengaruhi
plebitis
 Pencegahan dan pengendalian
plebitis
PENDAHULUAN
Pemasangan infus melalui vena perifer dapat
berisiko terjadinya plebitis
The incidence of infusion phlebitis is estimated to
be as high as 62% of patients with an intravenous
access device in place (Lundgren, Jordfeldt & Ek
1993).
Insiden Rate Plebitis di RSUD Lawang Tahun 2019
PARAMETER
Tahun 2019
Triwulan I Triwulan II Triwulan III Triwulan IV
Jumlah pasien plebitis N 1 4 3 81
Jumlah hari pemakaian IVL D 5.318 4.354 4399
4174
permil ‰ 0,19 0,92 0,68 19,41
Standart
‰ 1 1 1 1
Triwulan I
Triwulan II
Triwulan III
Triwulan IV
0.19 0.92
0.68
19.41
1 1 1
1
Trend Phlebitis
Tahun 2019 di RSUD Lawang Kabupaten Malang
Plebitis (‰) standart (‰)
PENGERTIAN
 Plebitis merupakan peradangan vena yang
disebabkan iritasi kimia, bakterial, dan mekanis yang
ditunjukkan dengan adanya daerah yang merah, nyeri
dan pembengkakan di daerah penusukan atau
sepanjang vena.
Secara klinis adanya keluhan nyeri, nyeri tekan,
bengkak, pengerasan, eritema dan hangat pada vena
oleh karena peradangan, infeksi dan/atau trombosis
TANDA –TANDA PLEBITIS
 Secara klinis :
Ada nyeri, nyeri tekan,bengkak,pengerasan,
eritema dan hangat pada vena
 Jika infeksi :
Kemerahan, demam, sakit, bengkak,
adanya pus atau kerusakan pada kulit
FAKTOR –FAKTOR YANG MEMPENGARUHI PLEBITIS
 Usia
 Jenis kelamin
 Kondisi dasar ( diabetes melitus,
infeksi, luka bakar )
 Faktor kimia seperti obat atau cairan yang
iritan
 Faktor mekanis seperti bahan, ukuran kateter,
lokasi dan lama kanulasi
 Agent infeksius
Catheter Related Infection Risk
Fibrin sheath,
Thrombus
HEMATOGENOUS,
From distant local Infection
Contaminated
Infusate
INS Visual Infusion Phlebitis (V.I.P.) Score, 2006
IV site appears healthy
No pain at IV site, no erythema,
No swelling
No palpable venous cord (all ages)
0 No signs of phlebitis
OBSERVE CANNULA
• Erythema at access site
• With or without pain 1
• Stop infusion if possible
• Identify additional resources
for management
• Remove IV if symptoms persist
• Erythema
• Pain at access site
• With or without edema
2
• Stop infusion if possible
• Identify additional resources
for management
• Remove IV if symptoms persist
• Erythema
• Pain at access site
• With or without edema
• Streak formation
• Palpable venous cord
3
• Stop infusion if possible
• Identify additional resources
for management
• Remove IV
• Notify primary service
• Erythema
• Pain at access site
• With or without edema
• Streak formation
• Palpable venous cord > 1 inch
• Purulent drainage
4
• Stop infusion and establish alternate
IV site
• Remove IV and culture site and catheter
tip
• Notify primary service
Infiltration Scale (INS 2006)
No symptoms 0
• Skin blanched
• Edema < 1 inch in any direction
• Cool to touch
• With or without pain
1
• Skin blanched
• Edema 1 – 6 inches in any direction
• Cool to touch
• With or without pain
2
• Skin blanched, translucent
• Gross edema > 6 inches in any direction
• Cool to touch
• Mild to moderate pain
• Possible numbness
3
• Skin blanched, translucent
• Skin tight, leaking
• Skin discolored, bruised, swollen
• Gross edema > 6 inches in any direction
• Deep pitting tissue edema
• Circulatory impairment
• Moderate – severe pain
• Infiltration of any amount of blood product, irritant, or vesicant
4
JENIS – JENIS PLEBITIS
1.Plebitis Kimia
2. Plebitis Mekanis
3. Plebitis Bakterial
1.Plebitis Kimia
 pH dan osmolaritas cairan infus yang ekstrem  pH ↓,
osmolaritas ↑
 Mikropartikel yang terlarut  yang terbentuk bila
partikel obat tidak larut sempurna selama
pencampuran  pemberian obat intravena
menggunakan filter 1 sampai 5 µm.
 Pemilihan material kateter intravaskuler yang
digunakan  silikon dan poliuretan kurang bersifat
iritasi dibanding politetrafluoroetilen (teflon),
polivinil klorida atau polietilen resiko tertinggi
2. PLEBITIS MEKANIS
 Penempatan kateter intravaskuler yang
tidak tepat
 Ukuran kateter intravaskuler yang tidak
sesuai dengan ukuran vena
 Cara pemasangan, pengawasan dan
perawatan yang kurang baik
 Laju pemberian yang tidak sesuai
3. PLEBITIS BAKTERIAL
 Hand hygiene tidak dilakukan
 Preparasi kulit tidak baik sebelum pemasangan infus
 Teknik aseptik tidak baik saat akan pemberian obat
atau cairan
 Kateter dipasang terlalu lama
 Tempat Tusukan Kateter tidak/ jarang diinspeksi secara
visual
 Alat – alat yang di gunakan rusak atau bocor atau
kadaluarsa
 Larutan infus terkontaminasi karena teknik aseptik yang
kurang baik pada saat pencampuran larutan
 Faktor virulen instrinsik dari mikroorganisme itu sendiri
PENATALAKSANAAN PENCEGAHAN PLEBITIS
1.HAND HYGIENE
2. PREPARASI KULIT
 Use alcohol followed by application of main disinfectant 10%
Povidone Iodine or 2% Chlorhexidine prep.
 Provides immediate kill as well as residual activity
 For Iodophor - 2-3 hrs
 For Chlorhexidine prep. - 6 hrs
 Process - 2 Steps
 Apply alcohol in circular motion outwards, allow it to dry
 Apply Povidone Iodine or Chlorhexidine in circular motion
outwards, allow it to dry
3. DRESSING / PENUTUP INFUS
 Use either sterile gauze or sterile transparent,
semi permeable dressing to cover the catheter site
 Replace catheter dressing if the dressing becomes
damp, loose, or visibly soiled
 Replace dressings at every 2 days for gauze
dressing and 72 hour for transparent dressing
CDC, Centre for Disease Control and Prevention, Guidelines for prevention of Intravascular catheter
related Infections, MMWR, 2002: 51 ( No. RR 10 )
4.Catheter care - Flushing
 All vascular access devices used should be flushed with 0.9% sodium chloride
(normal saline) or heparin to*
 Maintain catheter patency
 Prevent contact between incompatible fluids and medications
 Appropriate Flushing helps to reduce catheter thrombosis and thus CR-BSI risk**
 As thrombi or fibrin deposits could serve as a nidus for microbial colonization
 When catheter flushing is to be performed
 Just after catheter insertion
 Before and after each administration of medication
 od sampling
 Every 6-8 hours when catheter is not in use (Once a day - home care PICC’s )
 INS standards, 2006
 Single use flushing systems to be used, that is, do not use multiple use vials
 8% Syringes prepared by nurses are contaminated - Syringe tip, Fluid***
Touch contamination
Multiple use vials or their inappropriate usage
page 394, ** CDC, Centre for Disease Control and Prevention, Guidelines for prevention of IV catheter related Infections, MMWR, 2002: 51, Page 9 ( No. RR 10 ), ** APIC, Lynn
Hadaway, Webinar series 2006
Infusion Therapy in clinical practice Judy Hankins et al, 2nd Edition, The Infusion Nursing Society,
5. Appropriate use of equipment
1. Intravasular Access
Monitor and inspect catheter site regularly, the site should be
observed for any signs of inflammation, infection or malfunction
2.For any intravascular access
 Replace IV tubing and add on devices no more frequently than 72
hours
 Replace tubing used to administer blood products or lipids with in 24
hrs
Clean injection ports with 70% alcohol or an iodophor before accessing
3.IVD replacement
 Peripheral Venous : 72-96 hrs in adults / first signs of phlebitis,
 In pediatric patients, Do not routinely replace peripheral venous
catheters unless clinically indicated
 CVC’s / PICC / Hemodialysis / PA / Peripheral Arterial : NOT routinely*
The Peripheral Vascular Catheter (PVC)
Bundle
1. Performed hand hygiene before and after all
PVC procedures
2. Checking the PVCs insitu are still requared
3. Removing PVCs where there is extra vasation
or inflamation
4. Checking PVC dressing are intact
5. Considering removal of PVCs insitu longer
than 72 hours
NHS
• Pengumpulan data setiap hari
• Perhitungan setiap bulan
• Laporan setiap bulan,triwulan,semester, tahunan
• Insiden rate Plebitis:
Jumlah plebitis
--------------------------------- X 1000 = ( ‰ )
Hari pemakaian IV Kateter
Himpunan Perawat Pencegah dan
Pengendali Infeksi Indonesia (HIPPII)- Pusat
28
Replacement of Peripheral and Midline Catheters
1. There is no need to replace peripheral
catheters more frequently than every 72-96
hours to reduce risk of infection and phlebitis in
adults [36, 140, 141]. Category 1B
2. No recommendation is made regarding
replacement of peripheral catheters in adults
only when clinically indicated [142–144].
Unresolved issue
3. Replace peripheral catheters in children only
when clinically indicated [32, 33]. Category
1B
4. Replace midline catheters only when there is a
specific indication. Category II

More Related Content

What's hot

PELATIHAN KEBERSIHAN TANGAN.pptx
PELATIHAN KEBERSIHAN TANGAN.pptxPELATIHAN KEBERSIHAN TANGAN.pptx
PELATIHAN KEBERSIHAN TANGAN.pptx
YANTOTALAN
 
Sop sterilisasi alat medis
Sop sterilisasi alat medisSop sterilisasi alat medis
Sop sterilisasi alat medis
YadiSupriyadi20
 
Audit Kebersihan Tangan KKT.pptx
Audit Kebersihan Tangan KKT.pptxAudit Kebersihan Tangan KKT.pptx
Audit Kebersihan Tangan KKT.pptx
RiaSilviani1
 
Permenkes no. 27 tahun 2017 ttg Pedoman Ppencegahan dan Pengendalian Infeksi...
Permenkes no. 27 tahun 2017  ttg Pedoman Ppencegahan dan Pengendalian Infeksi...Permenkes no. 27 tahun 2017  ttg Pedoman Ppencegahan dan Pengendalian Infeksi...
Permenkes no. 27 tahun 2017 ttg Pedoman Ppencegahan dan Pengendalian Infeksi...
Adelina Hutauruk
 
PANDUAN CODE BLUE.pptx
PANDUAN CODE BLUE.pptxPANDUAN CODE BLUE.pptx
PANDUAN CODE BLUE.pptx
themzlotta
 
ICRA - manajemen risiko.pptx
ICRA - manajemen risiko.pptxICRA - manajemen risiko.pptx
ICRA - manajemen risiko.pptx
WawanWahyudi7
 
Prosedur Pemasangan Infus
Prosedur Pemasangan InfusProsedur Pemasangan Infus
Prosedur Pemasangan InfusYanzhe River's
 
POWER POINT PPI.pptx
POWER POINT PPI.pptxPOWER POINT PPI.pptx
POWER POINT PPI.pptx
puskesmasnurussalam1
 
profil indikator.docx
profil indikator.docxprofil indikator.docx
profil indikator.docx
YunitraDevi1
 
1# PENCATATAN DAN PELAPORAN PPI (1).pptx
1# PENCATATAN DAN PELAPORAN PPI (1).pptx1# PENCATATAN DAN PELAPORAN PPI (1).pptx
1# PENCATATAN DAN PELAPORAN PPI (1).pptx
RsudKualaPembuang
 
Kebijakan ppi-kemenkes
Kebijakan ppi-kemenkesKebijakan ppi-kemenkes
Kebijakan ppi-kemenkes
Fikri Jafar
 
SPO Komunikasi Efektif SBAR.docx
SPO Komunikasi Efektif SBAR.docxSPO Komunikasi Efektif SBAR.docx
SPO Komunikasi Efektif SBAR.docx
TyanBagoes
 
5.5.2.a Data supervisi atau hasil audit Program PPI.docx
5.5.2.a Data supervisi atau hasil audit Program PPI.docx5.5.2.a Data supervisi atau hasil audit Program PPI.docx
5.5.2.a Data supervisi atau hasil audit Program PPI.docx
Cristy665562
 
zoominar ppi april 2022.pptx
zoominar ppi april 2022.pptxzoominar ppi april 2022.pptx
zoominar ppi april 2022.pptx
nurulfadhilah505394
 
Surveilans pengendalian dan pencegahan infeksi di puskesmas
Surveilans pengendalian dan pencegahan infeksi di puskesmasSurveilans pengendalian dan pencegahan infeksi di puskesmas
Surveilans pengendalian dan pencegahan infeksi di puskesmas
I Putu Cahya Legawa
 
360552721-Laporan-Bulanan-Ppi-September-2017-Copy.docx
360552721-Laporan-Bulanan-Ppi-September-2017-Copy.docx360552721-Laporan-Bulanan-Ppi-September-2017-Copy.docx
360552721-Laporan-Bulanan-Ppi-September-2017-Copy.docx
citramedika3
 
konsep dan prinsip patient safety.ppt
konsep dan prinsip patient safety.pptkonsep dan prinsip patient safety.ppt
konsep dan prinsip patient safety.ppt
SriTursina
 
Fitriani pemasangan infus
Fitriani pemasangan infusFitriani pemasangan infus
Fitriani pemasangan infus
Chiyapuri
 
Pemasangan ngt
Pemasangan ngtPemasangan ngt
Pemasangan ngt
Chiyapuri
 

What's hot (20)

PELATIHAN KEBERSIHAN TANGAN.pptx
PELATIHAN KEBERSIHAN TANGAN.pptxPELATIHAN KEBERSIHAN TANGAN.pptx
PELATIHAN KEBERSIHAN TANGAN.pptx
 
Sop sterilisasi alat medis
Sop sterilisasi alat medisSop sterilisasi alat medis
Sop sterilisasi alat medis
 
BUNDLES HAIS KAP.pptx
BUNDLES HAIS KAP.pptxBUNDLES HAIS KAP.pptx
BUNDLES HAIS KAP.pptx
 
Audit Kebersihan Tangan KKT.pptx
Audit Kebersihan Tangan KKT.pptxAudit Kebersihan Tangan KKT.pptx
Audit Kebersihan Tangan KKT.pptx
 
Permenkes no. 27 tahun 2017 ttg Pedoman Ppencegahan dan Pengendalian Infeksi...
Permenkes no. 27 tahun 2017  ttg Pedoman Ppencegahan dan Pengendalian Infeksi...Permenkes no. 27 tahun 2017  ttg Pedoman Ppencegahan dan Pengendalian Infeksi...
Permenkes no. 27 tahun 2017 ttg Pedoman Ppencegahan dan Pengendalian Infeksi...
 
PANDUAN CODE BLUE.pptx
PANDUAN CODE BLUE.pptxPANDUAN CODE BLUE.pptx
PANDUAN CODE BLUE.pptx
 
ICRA - manajemen risiko.pptx
ICRA - manajemen risiko.pptxICRA - manajemen risiko.pptx
ICRA - manajemen risiko.pptx
 
Prosedur Pemasangan Infus
Prosedur Pemasangan InfusProsedur Pemasangan Infus
Prosedur Pemasangan Infus
 
POWER POINT PPI.pptx
POWER POINT PPI.pptxPOWER POINT PPI.pptx
POWER POINT PPI.pptx
 
profil indikator.docx
profil indikator.docxprofil indikator.docx
profil indikator.docx
 
1# PENCATATAN DAN PELAPORAN PPI (1).pptx
1# PENCATATAN DAN PELAPORAN PPI (1).pptx1# PENCATATAN DAN PELAPORAN PPI (1).pptx
1# PENCATATAN DAN PELAPORAN PPI (1).pptx
 
Kebijakan ppi-kemenkes
Kebijakan ppi-kemenkesKebijakan ppi-kemenkes
Kebijakan ppi-kemenkes
 
SPO Komunikasi Efektif SBAR.docx
SPO Komunikasi Efektif SBAR.docxSPO Komunikasi Efektif SBAR.docx
SPO Komunikasi Efektif SBAR.docx
 
5.5.2.a Data supervisi atau hasil audit Program PPI.docx
5.5.2.a Data supervisi atau hasil audit Program PPI.docx5.5.2.a Data supervisi atau hasil audit Program PPI.docx
5.5.2.a Data supervisi atau hasil audit Program PPI.docx
 
zoominar ppi april 2022.pptx
zoominar ppi april 2022.pptxzoominar ppi april 2022.pptx
zoominar ppi april 2022.pptx
 
Surveilans pengendalian dan pencegahan infeksi di puskesmas
Surveilans pengendalian dan pencegahan infeksi di puskesmasSurveilans pengendalian dan pencegahan infeksi di puskesmas
Surveilans pengendalian dan pencegahan infeksi di puskesmas
 
360552721-Laporan-Bulanan-Ppi-September-2017-Copy.docx
360552721-Laporan-Bulanan-Ppi-September-2017-Copy.docx360552721-Laporan-Bulanan-Ppi-September-2017-Copy.docx
360552721-Laporan-Bulanan-Ppi-September-2017-Copy.docx
 
konsep dan prinsip patient safety.ppt
konsep dan prinsip patient safety.pptkonsep dan prinsip patient safety.ppt
konsep dan prinsip patient safety.ppt
 
Fitriani pemasangan infus
Fitriani pemasangan infusFitriani pemasangan infus
Fitriani pemasangan infus
 
Pemasangan ngt
Pemasangan ngtPemasangan ngt
Pemasangan ngt
 

Similar to 254655522-Plebhitis-ppt.ppt

Prevention of nosocomial infections
Prevention of nosocomial infectionsPrevention of nosocomial infections
Prevention of nosocomial infections
Sachin Verma
 
Prevention of Catheter Associated Urinary Tract Infection ( CAUTI ) [compatib...
Prevention of Catheter Associated Urinary Tract Infection ( CAUTI ) [compatib...Prevention of Catheter Associated Urinary Tract Infection ( CAUTI ) [compatib...
Prevention of Catheter Associated Urinary Tract Infection ( CAUTI ) [compatib...
drnahla
 
Infection control measures in iv drug administration
Infection control measures in iv drug administrationInfection control measures in iv drug administration
Infection control measures in iv drug administration
kholeif
 
Cabsi cauti-vap-nurses
Cabsi cauti-vap-nursesCabsi cauti-vap-nurses
Cabsi cauti-vap-nurses
Dr. Kanwal Deep Singh Lyall
 
Infection control guidelines for Prevention of Peripheral Venous Catheter (PV...
Infection control guidelines for Prevention of Peripheral Venous Catheter (PV...Infection control guidelines for Prevention of Peripheral Venous Catheter (PV...
Infection control guidelines for Prevention of Peripheral Venous Catheter (PV...
drnahla
 
HAI.ppt
HAI.pptHAI.ppt
HAI.ppt
Masud Rana
 
CCN UNIT-3.pptx
CCN UNIT-3.pptxCCN UNIT-3.pptx
CCN UNIT-3.pptx
sats81
 
Care of the intravenous catheters
Care of the intravenous cathetersCare of the intravenous catheters
Care of the intravenous catheters
Society for Microbiology and Infection care
 
ANY WASTE GENERATED DURING THE DIAGNOSIS, TREATMENT OR IMMUNIZATION OF HUMA...
ANY WASTE GENERATED DURING  THE DIAGNOSIS, TREATMENT  OR IMMUNIZATION OF HUMA...ANY WASTE GENERATED DURING  THE DIAGNOSIS, TREATMENT  OR IMMUNIZATION OF HUMA...
ANY WASTE GENERATED DURING THE DIAGNOSIS, TREATMENT OR IMMUNIZATION OF HUMA...
ssuser3155141
 
Central venous access catheter
Central venous access catheterCentral venous access catheter
Central venous access catheter
Kathi Ravan
 
peripheral IV care.pptx
peripheral IV care.pptxperipheral IV care.pptx
peripheral IV care.pptx
Sandhya C
 
2010 cv annual ed central line care
2010 cv annual ed central line care2010 cv annual ed central line care
2010 cv annual ed central line care
capstonerx
 
hospital acquired infection HAI
hospital acquired infection HAIhospital acquired infection HAI
hospital acquired infection HAI
RevathyKD
 
Intravenous cannulation
Intravenous cannulationIntravenous cannulation
Intravenous cannulation
AYM NAZIM
 
Intravenous cannulation
Intravenous cannulationIntravenous cannulation
Intravenous cannulation
anaesthesiology-mgmcri
 
HIC PPT.pptx
HIC  PPT.pptxHIC  PPT.pptx
HIC PPT.pptx
shristichetri1
 
role of nurses in ICU in the nursing b.sc
role of nurses in ICU in the nursing b.scrole of nurses in ICU in the nursing b.sc
role of nurses in ICU in the nursing b.sc
DishaThakur53
 
Nosocomial infections
Nosocomial infectionsNosocomial infections
Nosocomial infections
drsadhana86
 
iv_catheter.ppt
iv_catheter.pptiv_catheter.ppt
iv_catheter.ppt
mousaderhem1
 
INTRAVENOUS-THERAPY.pptx
INTRAVENOUS-THERAPY.pptxINTRAVENOUS-THERAPY.pptx
INTRAVENOUS-THERAPY.pptx
KrizamayOngatAgger
 

Similar to 254655522-Plebhitis-ppt.ppt (20)

Prevention of nosocomial infections
Prevention of nosocomial infectionsPrevention of nosocomial infections
Prevention of nosocomial infections
 
Prevention of Catheter Associated Urinary Tract Infection ( CAUTI ) [compatib...
Prevention of Catheter Associated Urinary Tract Infection ( CAUTI ) [compatib...Prevention of Catheter Associated Urinary Tract Infection ( CAUTI ) [compatib...
Prevention of Catheter Associated Urinary Tract Infection ( CAUTI ) [compatib...
 
Infection control measures in iv drug administration
Infection control measures in iv drug administrationInfection control measures in iv drug administration
Infection control measures in iv drug administration
 
Cabsi cauti-vap-nurses
Cabsi cauti-vap-nursesCabsi cauti-vap-nurses
Cabsi cauti-vap-nurses
 
Infection control guidelines for Prevention of Peripheral Venous Catheter (PV...
Infection control guidelines for Prevention of Peripheral Venous Catheter (PV...Infection control guidelines for Prevention of Peripheral Venous Catheter (PV...
Infection control guidelines for Prevention of Peripheral Venous Catheter (PV...
 
HAI.ppt
HAI.pptHAI.ppt
HAI.ppt
 
CCN UNIT-3.pptx
CCN UNIT-3.pptxCCN UNIT-3.pptx
CCN UNIT-3.pptx
 
Care of the intravenous catheters
Care of the intravenous cathetersCare of the intravenous catheters
Care of the intravenous catheters
 
ANY WASTE GENERATED DURING THE DIAGNOSIS, TREATMENT OR IMMUNIZATION OF HUMA...
ANY WASTE GENERATED DURING  THE DIAGNOSIS, TREATMENT  OR IMMUNIZATION OF HUMA...ANY WASTE GENERATED DURING  THE DIAGNOSIS, TREATMENT  OR IMMUNIZATION OF HUMA...
ANY WASTE GENERATED DURING THE DIAGNOSIS, TREATMENT OR IMMUNIZATION OF HUMA...
 
Central venous access catheter
Central venous access catheterCentral venous access catheter
Central venous access catheter
 
peripheral IV care.pptx
peripheral IV care.pptxperipheral IV care.pptx
peripheral IV care.pptx
 
2010 cv annual ed central line care
2010 cv annual ed central line care2010 cv annual ed central line care
2010 cv annual ed central line care
 
hospital acquired infection HAI
hospital acquired infection HAIhospital acquired infection HAI
hospital acquired infection HAI
 
Intravenous cannulation
Intravenous cannulationIntravenous cannulation
Intravenous cannulation
 
Intravenous cannulation
Intravenous cannulationIntravenous cannulation
Intravenous cannulation
 
HIC PPT.pptx
HIC  PPT.pptxHIC  PPT.pptx
HIC PPT.pptx
 
role of nurses in ICU in the nursing b.sc
role of nurses in ICU in the nursing b.scrole of nurses in ICU in the nursing b.sc
role of nurses in ICU in the nursing b.sc
 
Nosocomial infections
Nosocomial infectionsNosocomial infections
Nosocomial infections
 
iv_catheter.ppt
iv_catheter.pptiv_catheter.ppt
iv_catheter.ppt
 
INTRAVENOUS-THERAPY.pptx
INTRAVENOUS-THERAPY.pptxINTRAVENOUS-THERAPY.pptx
INTRAVENOUS-THERAPY.pptx
 

Recently uploaded

CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
CANSA The Cancer Association of South Africa
 
FACIAL NERVE
FACIAL NERVEFACIAL NERVE
FACIAL NERVE
aditigupta1117
 
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdf
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdfComprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdf
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdf
Dr Rachana Gujar
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Ear Solutions (ESPL)
 
GIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure andGIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure and
MuzafarBohio
 
LEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptxLEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptx
ChetanSharma78255
 
Top Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima SpaTop Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima Spa
Chandrima Spa Ajman
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
eurohealthleaders
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
Chandrima Spa Ajman
 
The Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdfThe Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdf
Dr Rachana Gujar
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
Dr Rachana Gujar
 
Common Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptxCommon Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptx
patriciaava1998
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
Azreen Aj
 
Vicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdfVicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdf
Arunima620542
 
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
rightmanforbloodline
 
Unlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdfUnlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdf
Lift Ability
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
Canadian Cancer Survivor Network
 
PrudentRx: A Resource for Patient Education and Engagement
PrudentRx: A Resource for Patient Education and EngagementPrudentRx: A Resource for Patient Education and Engagement
PrudentRx: A Resource for Patient Education and Engagement
PrudentRx Program
 
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
gjsma0ep
 
Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
Dharma Homoeopathy
 

Recently uploaded (20)

CANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' CaregiversCANSA support - Caring for Cancer Patients' Caregivers
CANSA support - Caring for Cancer Patients' Caregivers
 
FACIAL NERVE
FACIAL NERVEFACIAL NERVE
FACIAL NERVE
 
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdf
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdfComprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdf
Comprehensive Rainy Season Advisory: Safety and Preparedness Tips.pdf
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
 
GIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure andGIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure and
 
LEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptxLEAD Innovation Launch_WHO Innovation Initiative.pptx
LEAD Innovation Launch_WHO Innovation Initiative.pptx
 
Top Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima SpaTop Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima Spa
 
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdfChampions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
Champions of Health Spotlight On Leaders Shaping Germany's Healthcare.pdf
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
 
The Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdfThe Power of Superfoods and Exercise.pdf
The Power of Superfoods and Exercise.pdf
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
 
Common Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptxCommon Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptx
 
Letter to MREC - application to conduct study
Letter to MREC - application to conduct studyLetter to MREC - application to conduct study
Letter to MREC - application to conduct study
 
Vicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdfVicarious movements or trick movements_AB.pdf
Vicarious movements or trick movements_AB.pdf
 
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
 
Unlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdfUnlocking the Secrets to Safe Patient Handling.pdf
Unlocking the Secrets to Safe Patient Handling.pdf
 
CCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer RehabpptxCCSN_June_06 2024_jones. Cancer Rehabpptx
CCSN_June_06 2024_jones. Cancer Rehabpptx
 
PrudentRx: A Resource for Patient Education and Engagement
PrudentRx: A Resource for Patient Education and EngagementPrudentRx: A Resource for Patient Education and Engagement
PrudentRx: A Resource for Patient Education and Engagement
 
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
 
Can Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdfCan Allopathy and Homeopathy Be Used Together in India.pdf
Can Allopathy and Homeopathy Be Used Together in India.pdf
 

254655522-Plebhitis-ppt.ppt

  • 1. PENCEGAHAN DAN PENGENDALIAN PLEBITIS Disampaikan Pada Pelatihan Pemasangan Infuse Pada tanggal 15 Februari 2020
  • 2. POKOK BAHASAN  Pendahuluan  Pengertian  Faktor –faktor yang mempengaruhi plebitis  Pencegahan dan pengendalian plebitis
  • 3. PENDAHULUAN Pemasangan infus melalui vena perifer dapat berisiko terjadinya plebitis The incidence of infusion phlebitis is estimated to be as high as 62% of patients with an intravenous access device in place (Lundgren, Jordfeldt & Ek 1993).
  • 4. Insiden Rate Plebitis di RSUD Lawang Tahun 2019 PARAMETER Tahun 2019 Triwulan I Triwulan II Triwulan III Triwulan IV Jumlah pasien plebitis N 1 4 3 81 Jumlah hari pemakaian IVL D 5.318 4.354 4399 4174 permil ‰ 0,19 0,92 0,68 19,41 Standart ‰ 1 1 1 1 Triwulan I Triwulan II Triwulan III Triwulan IV 0.19 0.92 0.68 19.41 1 1 1 1 Trend Phlebitis Tahun 2019 di RSUD Lawang Kabupaten Malang Plebitis (‰) standart (‰)
  • 5. PENGERTIAN  Plebitis merupakan peradangan vena yang disebabkan iritasi kimia, bakterial, dan mekanis yang ditunjukkan dengan adanya daerah yang merah, nyeri dan pembengkakan di daerah penusukan atau sepanjang vena. Secara klinis adanya keluhan nyeri, nyeri tekan, bengkak, pengerasan, eritema dan hangat pada vena oleh karena peradangan, infeksi dan/atau trombosis
  • 6. TANDA –TANDA PLEBITIS  Secara klinis : Ada nyeri, nyeri tekan,bengkak,pengerasan, eritema dan hangat pada vena  Jika infeksi : Kemerahan, demam, sakit, bengkak, adanya pus atau kerusakan pada kulit
  • 7. FAKTOR –FAKTOR YANG MEMPENGARUHI PLEBITIS  Usia  Jenis kelamin  Kondisi dasar ( diabetes melitus, infeksi, luka bakar )  Faktor kimia seperti obat atau cairan yang iritan  Faktor mekanis seperti bahan, ukuran kateter, lokasi dan lama kanulasi  Agent infeksius
  • 8. Catheter Related Infection Risk Fibrin sheath, Thrombus HEMATOGENOUS, From distant local Infection Contaminated Infusate
  • 9. INS Visual Infusion Phlebitis (V.I.P.) Score, 2006 IV site appears healthy No pain at IV site, no erythema, No swelling No palpable venous cord (all ages) 0 No signs of phlebitis OBSERVE CANNULA • Erythema at access site • With or without pain 1 • Stop infusion if possible • Identify additional resources for management • Remove IV if symptoms persist • Erythema • Pain at access site • With or without edema 2 • Stop infusion if possible • Identify additional resources for management • Remove IV if symptoms persist • Erythema • Pain at access site • With or without edema • Streak formation • Palpable venous cord 3 • Stop infusion if possible • Identify additional resources for management • Remove IV • Notify primary service • Erythema • Pain at access site • With or without edema • Streak formation • Palpable venous cord > 1 inch • Purulent drainage 4 • Stop infusion and establish alternate IV site • Remove IV and culture site and catheter tip • Notify primary service
  • 10. Infiltration Scale (INS 2006) No symptoms 0 • Skin blanched • Edema < 1 inch in any direction • Cool to touch • With or without pain 1 • Skin blanched • Edema 1 – 6 inches in any direction • Cool to touch • With or without pain 2 • Skin blanched, translucent • Gross edema > 6 inches in any direction • Cool to touch • Mild to moderate pain • Possible numbness 3 • Skin blanched, translucent • Skin tight, leaking • Skin discolored, bruised, swollen • Gross edema > 6 inches in any direction • Deep pitting tissue edema • Circulatory impairment • Moderate – severe pain • Infiltration of any amount of blood product, irritant, or vesicant 4
  • 11. JENIS – JENIS PLEBITIS 1.Plebitis Kimia 2. Plebitis Mekanis 3. Plebitis Bakterial
  • 12. 1.Plebitis Kimia  pH dan osmolaritas cairan infus yang ekstrem  pH ↓, osmolaritas ↑  Mikropartikel yang terlarut  yang terbentuk bila partikel obat tidak larut sempurna selama pencampuran  pemberian obat intravena menggunakan filter 1 sampai 5 µm.  Pemilihan material kateter intravaskuler yang digunakan  silikon dan poliuretan kurang bersifat iritasi dibanding politetrafluoroetilen (teflon), polivinil klorida atau polietilen resiko tertinggi
  • 13. 2. PLEBITIS MEKANIS  Penempatan kateter intravaskuler yang tidak tepat  Ukuran kateter intravaskuler yang tidak sesuai dengan ukuran vena  Cara pemasangan, pengawasan dan perawatan yang kurang baik  Laju pemberian yang tidak sesuai
  • 14. 3. PLEBITIS BAKTERIAL  Hand hygiene tidak dilakukan  Preparasi kulit tidak baik sebelum pemasangan infus  Teknik aseptik tidak baik saat akan pemberian obat atau cairan  Kateter dipasang terlalu lama  Tempat Tusukan Kateter tidak/ jarang diinspeksi secara visual  Alat – alat yang di gunakan rusak atau bocor atau kadaluarsa  Larutan infus terkontaminasi karena teknik aseptik yang kurang baik pada saat pencampuran larutan  Faktor virulen instrinsik dari mikroorganisme itu sendiri
  • 15.
  • 16.
  • 17.
  • 19. 2. PREPARASI KULIT  Use alcohol followed by application of main disinfectant 10% Povidone Iodine or 2% Chlorhexidine prep.  Provides immediate kill as well as residual activity  For Iodophor - 2-3 hrs  For Chlorhexidine prep. - 6 hrs  Process - 2 Steps  Apply alcohol in circular motion outwards, allow it to dry  Apply Povidone Iodine or Chlorhexidine in circular motion outwards, allow it to dry
  • 20. 3. DRESSING / PENUTUP INFUS  Use either sterile gauze or sterile transparent, semi permeable dressing to cover the catheter site  Replace catheter dressing if the dressing becomes damp, loose, or visibly soiled  Replace dressings at every 2 days for gauze dressing and 72 hour for transparent dressing CDC, Centre for Disease Control and Prevention, Guidelines for prevention of Intravascular catheter related Infections, MMWR, 2002: 51 ( No. RR 10 )
  • 21.
  • 22. 4.Catheter care - Flushing  All vascular access devices used should be flushed with 0.9% sodium chloride (normal saline) or heparin to*  Maintain catheter patency  Prevent contact between incompatible fluids and medications  Appropriate Flushing helps to reduce catheter thrombosis and thus CR-BSI risk**  As thrombi or fibrin deposits could serve as a nidus for microbial colonization  When catheter flushing is to be performed  Just after catheter insertion  Before and after each administration of medication  od sampling  Every 6-8 hours when catheter is not in use (Once a day - home care PICC’s )  INS standards, 2006  Single use flushing systems to be used, that is, do not use multiple use vials  8% Syringes prepared by nurses are contaminated - Syringe tip, Fluid*** Touch contamination Multiple use vials or their inappropriate usage page 394, ** CDC, Centre for Disease Control and Prevention, Guidelines for prevention of IV catheter related Infections, MMWR, 2002: 51, Page 9 ( No. RR 10 ), ** APIC, Lynn Hadaway, Webinar series 2006 Infusion Therapy in clinical practice Judy Hankins et al, 2nd Edition, The Infusion Nursing Society,
  • 23.
  • 24. 5. Appropriate use of equipment 1. Intravasular Access Monitor and inspect catheter site regularly, the site should be observed for any signs of inflammation, infection or malfunction 2.For any intravascular access  Replace IV tubing and add on devices no more frequently than 72 hours  Replace tubing used to administer blood products or lipids with in 24 hrs Clean injection ports with 70% alcohol or an iodophor before accessing 3.IVD replacement  Peripheral Venous : 72-96 hrs in adults / first signs of phlebitis,  In pediatric patients, Do not routinely replace peripheral venous catheters unless clinically indicated  CVC’s / PICC / Hemodialysis / PA / Peripheral Arterial : NOT routinely*
  • 25. The Peripheral Vascular Catheter (PVC) Bundle 1. Performed hand hygiene before and after all PVC procedures 2. Checking the PVCs insitu are still requared 3. Removing PVCs where there is extra vasation or inflamation 4. Checking PVC dressing are intact 5. Considering removal of PVCs insitu longer than 72 hours NHS
  • 26. • Pengumpulan data setiap hari • Perhitungan setiap bulan • Laporan setiap bulan,triwulan,semester, tahunan • Insiden rate Plebitis: Jumlah plebitis --------------------------------- X 1000 = ( ‰ ) Hari pemakaian IV Kateter
  • 27.
  • 28. Himpunan Perawat Pencegah dan Pengendali Infeksi Indonesia (HIPPII)- Pusat 28
  • 29. Replacement of Peripheral and Midline Catheters 1. There is no need to replace peripheral catheters more frequently than every 72-96 hours to reduce risk of infection and phlebitis in adults [36, 140, 141]. Category 1B 2. No recommendation is made regarding replacement of peripheral catheters in adults only when clinically indicated [142–144]. Unresolved issue 3. Replace peripheral catheters in children only when clinically indicated [32, 33]. Category 1B 4. Replace midline catheters only when there is a specific indication. Category II